Inverse agonist effects of the cannabinoid CB1 receptor antagonist SR141716A in rat brain.

被引：0
|
作者：
Sim-Selley, LJ [1 ]
Brunk, LK [1 ]
Selley, DE [1 ]
机构：
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
来源：
FASEB JOURNAL | 2000年 / 14卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
781
引用
收藏
页码：A1447 / A1447
页数：1
相关论文
共 50 条
  • [1] SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
    Landsman, RS
    Burkey, TH
    Consroe, P
    Roeske, WR
    Yamamura, HI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (01) : R1 - R2
  • [2] Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
    Mansbach, RS
    Rovetti, CC
    Winston, EN
    Lowe, JA
    PSYCHOPHARMACOLOGY, 1996, 124 (04) : 315 - 322
  • [3] Functional inverse agonism of SR141716A on rat and human central cannabinoid CB1 receptor
    Valdizan, E. M.
    Mato, S.
    Pazos, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 72 - 72
  • [4] Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist
    Hirst, RA
    Almond, SL
    Lambert, DG
    NEUROSCIENCE LETTERS, 1996, 220 (02) : 101 - 104
  • [5] The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus
    Tzavara, ET
    Perry, KW
    Rodriguez, DE
    Bymaster, FP
    Nomikos, GG
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 426 (03) : R3 - R4
  • [6] INTRACELLULAR EMETIC SIGNALING OF THE CANNABINOID CB1 RECEPTOR INVERSE AGONIST/ANTAGONIST SR141716A IN THE LEAST SHREW ANIMAL MODEL OF VOMITING
    Daily, Z.
    Sun, Y.
    Belkacemi, L.
    Darmani, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 180 - 181
  • [7] Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal
    Beardsley, PM
    Martin, BR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (01) : 47 - 53
  • [8] SR141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine
    Masserano, JM
    Karoum, F
    Wyatt, RJ
    BEHAVIOURAL PHARMACOLOGY, 1999, 10 (04): : 429 - 432
  • [9] Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)
    van Diepen, Hester
    Schlicker, Eberhard
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 378 (04) : 345 - 369
  • [10] Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)
    Hester van Diepen
    Eberhard Schlicker
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 378 : 345 - 369
12345